日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial

纳武利尤单抗联合伊匹木单抗治疗晚期卵巢癌和子宫内膜透明细胞癌:一项非随机临床试验

Gao, Bo; Carlino, Matteo S; Michael, Michael; Underhill, Craig; Marshall, Henry; Gunjur, Ashray; So, Jane; Kee, Damien; Antill, Yoland; Lam, Wei-Sen; Chan, Howard; Harrup, Rosemary; Hamilton, Anne; Grady, John; Ballinger, Mandy; Tavancheh, Elnaz; Yoon, Won-Hee; Palmer, Jodie; Thomas, David; Wilkie, Kylie; Cebon, Jonathan; Klein, Oliver

Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.

先天性传感器 NOD2 中常见的遗传性功能丧失突变会导致对癌症免疫疗法产生异常的免疫反应

Barnet Megan B, Jackson Katherine J L, Masle-Farquhar Etienne, Russell Amanda, Burnett Deborah L, Chye Adrian, Jara Chris J, Faulks Megan, Mawson Amanda, Peters Timothy J, Brink Robert, Wright Katherine, Allen India, Junankar Simon, Davis Ian D, Heller Gillian, Khan Zia, Bruce Jeffrey, Yang Cindy, Prokopec Stephenie, Pugh Trevor, Behren Andreas, Hold Georgina L, Zhang Fan, Cooper Wendy A, Gao Bo, Nagrial Adnan, Joshua Anthony M, John Thomas, Peters Geoffrey, Hui Rina, Boyer Michael, Blinman Prunella L, Kao Steven C, Cebon Jonathan, Goodnow Christopher C

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

阻断共抑制分子PD-1可激活黑色素瘤中ILC2依赖的抗肿瘤免疫

Jacquelot, Nicolas; Seillet, Cyril; Wang, Minyu; Pizzolla, Angela; Liao, Yang; Hediyeh-Zadeh, Soroor; Grisaru-Tal, Sharon; Louis, Cynthia; Huang, Qiutong; Schreuder, Jaring; Souza-Fonseca-Guimaraes, Fernando; de Graaf, Carolyn A; Thia, Kevin; Macdonald, Sean; Camilleri, Mary; Luong, Kylie; Zhang, Shengbo; Chopin, Michael; Molden-Hauer, Tristan; Nutt, Stephen L; Umansky, Viktor; Ciric, Bogoljub; Groom, Joanna R; Foster, Paul S; Hansbro, Philip M; McKenzie, Andrew N J; Gray, Daniel H D; Behren, Andreas; Cebon, Jonathan; Vivier, Eric; Wicks, Ian P; Trapani, Joseph A; Munitz, Ariel; Davis, Melissa J; Shi, Wei; Neeson, Paul J; Belz, Gabrielle T

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

更正:BCL-XL 是治疗恶性胸膜间皮瘤的一个可靶向靶点。

Arulananda, Surein; O'Brien, Megan; Evangelista, Marco; Harris, Tiffany J; Steinohrt, Nikita S; Jenkins, Laura J; Walkiewicz, Marzena; O'Donoghue, Robert J J; Poh, Ashleigh R; Thapa, Bibhusal; Williams, David S; Leong, Trishe; Mariadason, John M; Li, Xia; Cebon, Jonathan; Lee, Erinna F; John, Thomas; Fairlie, W Douglas

Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538

伊匹木单抗和纳武利尤单抗联合免疫疗法治疗晚期肾上腺皮质癌患者:CA209-538 亚组分析

Klein, Oliver; Senko, Clare; Carlino, Matteo S; Markman, Ben; Jackett, Louise; Gao, Bo; Lum, Caroline; Kee, Damien; Behren, Andreas; Palmer, Jodie; Cebon, Jonathan

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma

PDCD1多态性可能预测转移性黑色素瘤患者对PD-1抑制剂的反应

Parakh, Sagun; Musafer, Ashan; Paessler, Sabrina; Witkowski, Tom; Suen, Connie S N Li Wai; Tutuka, Candani S A; Carlino, Matteo S; Menzies, Alexander M; Scolyer, Richard A; Cebon, Jonathan; Dobrovic, Alexander; Long, Georgina V; Klein, Oliver; Behren, Andreas

Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses

Ropporin-1 和 1B 在人类黑色素瘤中广泛表达,并能诱发强烈的体液免疫反应。

Da Gama Duarte, Jessica; Woods, Katherine; Quigley, Luke T; Deceneux, Cyril; Tutuka, Candani; Witkowski, Tom; Ostrouska, Simone; Hudson, Chris; Tsao, Simon Chang-Hao; Pasam, Anupama; Dobrovic, Alexander; Blackburn, Jonathan M; Cebon, Jonathan; Behren, Andreas

Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial

评估纳武利尤单抗和伊匹木单抗联合免疫疗法治疗晚期胆道癌患者的疗效:一项II期非随机临床试验的亚组分析

Klein, Oliver; Kee, Damien; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Jackett, Louise; Lum, Caroline; Behren, Andreas; Palmer, Jodie; Tebbutt, Niall C; Carlino, Matteo S; Cebon, Jonathan

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

一项随机、双盲 II 期临床试验的结果显示,在接受切除手术的高危黑色素瘤患者中,NY-ESO-1 疫苗联合 ISCOMATRIX 佐剂与单独使用 ISCOMATRIX 佐剂的疗效存在差异。

Cebon, Jonathan S; Gore, Martin; Thompson, John F; Davis, Ian D; McArthur, Grant A; Walpole, Euan; Smithers, Mark; Cerundolo, Vincenzo; Dunbar, P Rod; MacGregor, Duncan; Fisher, Cyril; Millward, Michael; Nathan, Paul; Findlay, Michael P N; Hersey, Peter; Evans, T R Jeffry; Ottensmeier, Christian Hermann; Marsden, Jeremy; Dalgleish, Angus G; Corrie, Pippa G; Maria, Marples; Brimble, Margaret; Williams, Geoff; Winkler, Sintia; Jackson, Heather M; Endo-Munoz, Liliana; Tutuka, Candani S A; Venhaus, Ralph; Old, Lloyd J; Haack, Dennis; Maraskovsky, Eugene; Behren, Andreas; Chen, Weisan

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

转移性黑色素瘤患者免疫检查点抑制剂诱发急性肾损伤的组织学诊断:回顾性病例系列报告

Hultin, Sebastian; Nahar, Kazi; Menzies, Alexander M; Long, Georgina V; Fernando, Suran L; Atkinson, Victoria; Cebon, Jonathan; Wong, Muh Geot